EBITDA of Supernus Pharmaceuticals, Inc.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. The company's product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which has completed Phase IIb trial that is used for the treatment of ADHD. It also develops SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
|CHKE Cherokee Inc.||NASDAQ > Consumer Non-Durables > Apparel||4.89|
|CAR Avis Budget Group, Inc.||NASDAQ > Consumer Services > Rental/Leasing Companies||4.89|
|PBPB Potbelly Corporation||NASDAQ > Consumer Services > Restaurants||4.89|
|INFN Infinera Corporation||NASDAQ > Public Utilities > Telecommunications Equipment||4.90|
|KRYS Krystal Biotech, Inc.||NASDAQ > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||4.90|
|WMS Advanced Drainage Systems, Inc.||NYSE > Capital Goods > Containers/Packaging||4.91|
|SUPN Supernus Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||4.91|
|PCO Pendrell Corporation||NASDAQ > Miscellaneous > Multi-Sector Companies||879.05|
|WTM White Mountains Insurance Group, Ltd.||NYSE > Finance > Property-Casualty Insurers||938.42|
|DCIX Diana Containerships Inc.||NASDAQ > Transportation > Marine Transportation||1,903.21|
|SEB Seaboard Corporation||NYSEMKT > Finance > Investment Bankers/Brokers/Service||2,890.09|
|BRK-A Berkshire Hathaway Inc.||NYSE > Finance > Property & Casualty Insurance||187,384.70|
|BRK-B Berkshire Hathaway Inc.||NYSE > Finance > Property & Casualty Insurance||187,384.70|